Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gene therapy
|
| gptkbp:antigen |
gptkb:CD19
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
gptkb:Juno_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
JCAR015
|
| gptkbp:intendedUse |
B-cell acute lymphoblastic leukemia
|
| gptkbp:mechanismOfAction |
Genetically engineered T cells targeting CD19-positive cells
|
| gptkbp:routeOfAdministration |
Intravenous
|
| gptkbp:status |
Development discontinued
|
| gptkbp:trial |
gptkb:ROCKET_trial
|
| gptkbp:trialOutcome |
Trial halted due to patient deaths
|
| gptkbp:bfsParent |
gptkb:Juno_Therapeutics
|
| gptkbp:bfsLayer |
5
|